This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200703-417OCv1 176/4/356    most recent Alert me when this article is cited Alert me if a correction is posted Services Related articles in AJRCCM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sethi, S. Articles by Murphy, T. F. Search for Related Content PubMed PubMed Citation Articles by Sethi, S. Articles by Murphy, T. F.

Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease

¹ Division of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, University at Buffalo, State University of New York, Buffalo, New York; ² Veterans Affairs Western New York Healthcare System, Buffalo, New York; and ³ Division of Infectious Diseases, Departments of Medicine and Microbiology, and ⁴ Department of Biostatistics, University at Buffalo, State University of New York, Buffalo, New York

Correspondence and requests for reprints should be addressed to Sanjay Sethi, M.D., Veterans Affairs Western New York Healthcare System (151), 3495 Bailey Avenue, Buffalo, NY 14215. E-mail: ssethi{at}buffalo.edu

Rationale: Increased bacterial concentration (load) in the lower airways and new bacterial strain acquisition have been posited as mechanisms for chronic obstructive pulmonary disease (COPD) exacerbations. Bacterial concentrations are higher during exacerbation than during stable disease; however, these studies are cross sectional and devoid of strain typing.

Objectives: To determine if the increased bacterial concentrations function as a separate mechanism for exacerbation induction independent of new strain acquisition.

Methods: In a prospective, longitudinal cohort of patients with COPD, the relationship between exacerbation occurrence, sputum bacterial concentrations, and new strain acquisition was examined.

Measurements and Main Results: Clinical information, quantitative sputum cultures, and molecular typing of potential bacterial pathogen isolates. Over 81 months, 104 subjects completed 3,009 clinic visits, 560 (19.6%) during exacerbations and 2,449 (80.4%) during stable disease. Among preexisting strains, sputum concentrations of Nontypeable Haemophilus influenzae and Haemophilus haemolyticus were not different in exacerbation versus stable disease. Moraxella catarrhalis (stable, 10^{8.38 ± 0.13} [mean ± SEM] vs. exacerbation, 10^{7.78 ± 0.26}; p = 0.02) and Streptococcus pneumoniae (stable, 10^{8.42 ± 0.21} vs. exacerbation, 10^{7.76 ± 0.52}; p = 0.07) concentrations were lower during exacerbations compared with stable periods. Concentrations of new strains of H. influenzae (stable, 10^{7.28 ± 0.15} vs. exacerbation, 10^{7.76 ± 0.17}; p = 0.04) and M. catarrhalis (stable, 10^{7.85 ± 0.15} vs. exacerbation, 10^{8.37 ± 0.14}; p = 0.02), were increased during exacerbations; however, the differences were small.

Conclusions: Change in bacterial load is unlikely to be an important mechanism for exacerbations. Better understanding of the host–pathogen interaction, rather than enumerating bacteria in respiratory samples, is required to provide new insights into bacterial infection in COPD.

Key Words: bacteria • chronic obstructive pulmonary disease • exacerbation

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Bacterial concentrations in the lower airways are higher during exacerbations of chronic obstructive pulmonary disease; however, it is not known if the increased bacterial concentrations are independent of acquisition of new strains and function as a separate mechanism for exacerbation induction. What This Study Adds to the Field Sputum concentrations of preexisting bacterial strains were not higher during exacerbations. Among new strains, small increases were seen. These results demonstrate that change in bacterial load is unlikely to be an important mechanism for exacerbations of COPD.

 

Related articles in AJRCCM:

Host–Pathogen Interactions during COPD Exacerbations: Moving on from Microbiology by Numbers?

Tom M. A. Wilkinson
AJRCCM 2007 176: 323-325. [Full Text]  

This article has been cited by other articles:

				M. Miravitlles, A. Marin, E. Monso, S. Vila, C. de la Roza, R. Hervas, C. Esquinas, M. Garcia, L. Millares, J. Morera, et al. Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD Eur. Respir. J., November 1, 2009; 34(5): 1066 - 1071. [Abstract] [Full Text] [PDF]

				S. P. W. de Vries, H. J. Bootsma, J. P. Hays, and P. W. M. Hermans Molecular Aspects of Moraxella catarrhalis Pathogenesis Microbiol. Mol. Biol. Rev., September 1, 2009; 73(3): 389 - 406. [Abstract] [Full Text] [PDF]

				G. G. Brusselle, T. Demoor, K. R. Bracke, C-A. Brandsma, and W. Timens Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur. Respir. J., July 1, 2009; 34(1): 219 - 230. [Abstract] [Full Text] [PDF]

				W. Janssens, A. Lehouck, C. Carremans, R. Bouillon, C. Mathieu, and M. Decramer Vitamin D Beyond Bones in Chronic Obstructive Pulmonary Disease: Time to Act Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 630 - 636. [Abstract] [Full Text] [PDF]

				P. E. Bratcher, I. H. Park, S. K. Hollingshead, and M. H. Nahm Production of a unique pneumococcal capsule serotype belonging to serogroup 6 Microbiology, February 1, 2009; 155(2): 576 - 583. [Abstract] [Full Text] [PDF]

				S. Sethi and T. F. Murphy Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., November 27, 2008; 359(22): 2355 - 2365. [Full Text] [PDF]

				B. Pang, W. Hong, S. L. West-Barnette, N. D. Kock, and W. E. Swords Diminished ICAM-1 Expression and Impaired Pulmonary Clearance of Nontypeable Haemophilus influenzae in a Mouse Model of Chronic Obstructive Pulmonary Disease/Emphysema Infect. Immun., November 1, 2008; 76(11): 4959 - 4967. [Abstract] [Full Text] [PDF]

				B. Pang, D. Winn, R. Johnson, W. Hong, S. West-Barnette, N. Kock, and W. E. Swords Lipooligosaccharides Containing Phosphorylcholine Delay Pulmonary Clearance of Nontypeable Haemophilus influenzae Infect. Immun., May 1, 2008; 76(5): 2037 - 2043. [Abstract] [Full Text] [PDF]

				S. Sethi and T. F. Murphy Bacterial Load and Exacerbations of COPD Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1049 - 1049. [Full Text] [PDF]

				H. Abusriwil and R. A. Stockley Bacterial Load and Exacerbations of COPD Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1048 - 1049. [Full Text] [PDF]

				H. Abusriwil and R. A. Stockley The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617. [Abstract] [Full Text] [PDF]

				A. Sykes, P. Mallia, and S. L. Johnston Diagnosis of Pathogens in Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2007; 4(8): 642 - 646. [Abstract] [Full Text] [PDF]

				T. M. A. Wilkinson Host Pathogen Interactions during COPD Exacerbations: Moving on from Microbiology by Numbers? Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 323 - 325. [Full Text] [PDF]